Excision BioTherapeutics September 6, 2017 veweb Press Release “HIV Cure-Focused Excision BioTherapeutics Secures $10 Million in Seed Funding” Related Posts Mina Therapeutics "Agreement to Develop Novel Treatment Approaches for Fibrotic Liver Diseases" AFT Pharmaceuticals “Maxigesic® Partnered for Commonwealth of Independent States” Mesoblast “Celgene Enters Into Equity Placement and Right of First Refusal Agreement”